How AI Search Is Recommending At-Home STD Tests

AI platforms are reshaping how consumers discover and choose at-home STD testing services. When a buyer asks ChatGPT, Perplexity, or Gemini for the best at-home STD test, the response functions as a shortlist. The brands that appear in ranked positions gain a structural advantage over those that are merely listed or described neutrally.

The LLM Authority Index benchmark for June 2026 reveals a market where recommendation power is highly concentrated around a small set of brands. Nurx leads with the highest AI Authority Value at $2.80M, capturing 15% of the total $18.67M monthly opportunity. Everlywell ranks second but shows a significant gap between raw visibility and recommendation conversion. Several well-known testing brands appear in AI responses but rarely receive ranked recommendations, creating a clear divide between being mentioned and being chosen.

Methodology

1. Market studied: At-home STD test services and direct-to-consumer health testing brands.
2. Brands/entities included: Everlywell, Health Testing Centers, Labcorp OnDemand, LetsGetChecked, myLAB Box, Nurx, PlushCare, Priority STD Testing, QuestDirect, STDcheck.com.
3. Data collection date/window: June 2026.
4. AI platforms tested: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity.
5. Number of prompts tested: Prompt count was not provided; 1,336 observations were analyzed across three public clusters.
6. Prompt categories: Discovery (Best At-Home Health Tests), comparison (At-Home Health Test Comparisons), and decision-stage (At-Home Health Test Pricing and Cost) prompts.
7. Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of sentiment or rank.
8. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality recommendation or ranked recommendation that earns recommendation credit. Visibility is not the same as recommendation credit.
9. Ranking/scoring metrics used: Valid recommendation coverage, top-3 rate, top-1 rate, average recommended rank, net sentiment score, monthly AI Authority Value, monthly AI Recommendation Value, and captured share of AI opportunity.
10. Limitations: This is a point-in-time benchmark. AI outputs can change. Modeled values are estimates and not revenue. This report is not a full audit or full market census. Only three of ten total prompt clusters are included in this public analysis.

Key Findings

Recommendation power is concentrated in two brands. Nurx and Everlywell together capture 20% of the total $18.67M monthly AI opportunity. Nurx leads with $2.80M in modeled AI Authority Value, driven by strong top-1 recommendation rates on ChatGPT and Perplexity. Everlywell holds second place with $936.5K but is the most visible brand overall, appearing in 62.9% of all AI responses. The gap between first and second place is substantial, and the gap between second place and the rest of the field is wider still.

Visibility does not equal recommendation. Everlywell appears in 62.9% of responses but its valid recommendation coverage is only 13.7%. myLAB Box appears in 32.6% of responses but captures just 1.1% of the total monthly opportunity. STDcheck.com appears in 6.2% of responses and receives zero ranked recommendations across all platforms. The benchmark shows that being named by an AI system is not the same as being chosen by one.

The pricing and cost cluster rewards brands with transparent information. The decision-stage cluster carries the highest commercial intent multiplier in the dataset. Nurx leads this cluster with $745K in modeled authority value. LetsGetChecked performs its strongest here as well. Brands without clear, search-visible pricing information, including Priority STD Testing and Health Testing Centers, are rarely recommended in decision-stage prompts, suggesting that information gaps create recommendation gaps at the highest-intent stage of buyer discovery.

Platform performance varies significantly across the category. Nurx achieves its strongest recommendation position on ChatGPT and Perplexity, where its top-1 rate exceeds 5%. Everlywell performs best on Perplexity and Google AI Mode. LetsGetChecked shows its highest recommendation coverage on Copilot and Google AI Mode, exceeding 14% on both. These platform differences indicate that citation architecture and source visibility are not uniform and that a brand's recommendation strength depends partly on which platform a buyer uses.

Several brands are commercially invisible despite category-relevant positioning. STDcheck.com, a brand whose name is directly tied to the category, receives zero ranked recommendations across all platforms measured. On Gemini, it appears in 21.4% of responses, yet none of those appearances result in a recommendation. QuestDirect and Health Testing Centers show similar patterns: meaningful raw presence with near-zero recommendation conversion.

What Changed in the Market

Buyers are no longer moving only from a Google search result to a brand website. They are now asking AI systems to compare at-home STD test providers, explain test accuracy, summarize pricing, surface alternatives, and recommend shortlists. This shift is particularly significant in health services, where trust, clinical credibility, and clear service information directly influence whether a brand is recommended or merely listed.

For at-home STD testing, a trust-heavy and privacy-sensitive category, the benchmark evidence suggests that AI systems favor brands with strong entity signals, clear service descriptions, and visible clinical or regulatory credibility. Brands that appear consistently in comparison articles, review platforms, and official health content are more likely to be mentioned. Brands that also appear in ranked lists, structured comparison data, and authoritative editorial sources are more likely to receive positive recommendation credit.

The concentration effect visible in this benchmark is self-reinforcing. As AI systems recommend Nurx more frequently, the brand's citation footprint grows, making it more likely to be recommended in future responses. This compounding advantage is difficult for lower-ranked brands to overcome without deliberate content and entity strategy. The market does not stand still while brands wait.

A category like at-home STD testing also carries heightened sensitivity around framing. AI systems navigating health and privacy topics may apply more cautious language, which can depress recommendation rates even for legitimate brands with strong products. Brands that rely on general awareness rather than structured, retrievable service evidence may find themselves caught in neutral framing regardless of their actual market position.

What the Benchmark Found

Nurx leads the category with a monthly modeled AI Authority Value of $2.80M and a captured share of approximately 15% of the total opportunity. Its valid recommendation coverage is 4.7%, but its average recommended rank of 1.83 is the strongest in the market. On ChatGPT and Perplexity, Nurx achieves top-1 recommendation rates of 5.9% and 8.2% respectively. When AI systems recommend Nurx, the benchmark shows they tend to place it first. The brand appears in 19.2% of all observations and converts a higher proportion of those appearances into ranked recommendations than any other brand in the dataset.

Everlywell is the most visible brand in the category, appearing in 62.9% of all AI responses. Its monthly modeled AI Authority Value of $936.5K places it second overall. Everlywell achieves a top-3 recommendation rate of 11.5% and a top-1 rate of 8.6%, with an average rank of 1.43 when it does receive a recommendation. However, its valid recommendation coverage of 13.7% is lower than its visibility would suggest. The brand is widely discussed but not consistently advanced into ranked positions. On Gemini and Google AI Mode, Everlywell performs well; on ChatGPT its recommendation coverage drops to 11.2%, a pattern worth monitoring.

LetsGetChecked holds the third position with a monthly modeled AI Authority Value of $337.5K. It appears in 49.6% of responses and achieves a valid recommendation coverage of 10.9%. Its top-3 rate of 8.5% and average rank of 2.08 reflect consistent but not dominant performance. LetsGetChecked performs best on Copilot and Google AI Mode, where its recommendation coverage exceeds 14%. The brand is strongest in the pricing and cost cluster, suggesting AI systems associate it with value-conscious buyer intent more reliably than with discovery or comparison intent.

myLAB Box appears in 32.6% of AI responses but captures only 1.1% of the total monthly opportunity, with a modeled AI Authority Value of $208K. Its valid recommendation coverage of 7.3% is moderate, but its average rank of 2.59 is the weakest among brands that receive recommendations at all. The brand carries high neutral visibility, meaning it is frequently mentioned without being positively recommended. On Copilot, myLAB Box performs better with an 11.8% recommendation coverage rate, but on ChatGPT that coverage drops to 3.5%, indicating a platform-specific framing problem.

Labcorp OnDemand holds a monthly modeled AI Authority Value of $178.5K with a valid recommendation coverage of 4.3%. The brand appears in 23.3% of responses and achieves a top-3 rate of 2.9%. Its average rank of 2.30 is respectable given its overall recommendation volume. Labcorp OnDemand benefits from the parent brand's clinical credibility, which may explain why the benchmark records it with the highest positive sentiment score among major competitors. That credibility is an asset, but it has not yet translated into recommendation volume.

STDcheck.com represents the clearest example in this dataset of a brand that is present but commercially invisible. It appears in 6.2% of all AI responses and receives zero ranked recommendations across all platforms. On Gemini alone it appears in 21.4% of responses, yet none of those appearances produce a recommendation. The analysis found that AI systems appear aware of STDcheck.com as an entity but do not place it on the buyer shortlist. The gap between category-name relevance and recommendation performance is among the most striking findings in the benchmark.

PlushCare, Priority STD Testing, Health Testing Centers, and QuestDirect collectively represent the lower tier of the market. Each has limited recommendation presence across the platforms measured. Priority STD Testing and Health Testing Centers show negligible recommendation coverage. PlushCare and QuestDirect have some measurable presence but have not established consistent recommendation patterns in any platform or prompt cluster captured in this dataset.

Why Visibility Is Not Enough

A brand can appear in AI answers and still fail to win the buyer shortlist. That distinction is the central insight of this benchmark, and the at-home STD testing data illustrates it clearly.

Raw mention presence measures how often a company is named in an AI response. Valid recommendation coverage measures how often a company is actually recommended or shortlisted. These are different signals with different commercial consequences. Everlywell is named in 62.9% of responses, but only 13.7% of those appearances earn recommendation credit. myLAB Box is named in 32.6% of responses but captures just 1.1% of the total modeled monthly opportunity.

Top-three placement and rank-one placement carry more commercial weight than raw visibility. A brand that appears first in an AI response captures structurally more buyer attention than a brand that appears fifth or is mentioned without a rank. Nurx averages a recommended rank of 1.83, the strongest in the market. myLAB Box averages 2.59. That difference in average position, across thousands of AI responses, compounds into a significant recommendation advantage over time.

Neutral or cautionary mentions do not earn recommendation credit. STDcheck.com appears in AI responses but with a positive visibility rate of only 0.5%. The brand is present in answers but not endorsed. That presence may create a false sense of AI discovery performance if a brand measures only raw mentions.

Citation frequency is not endorsement. A brand can be cited or named in multiple AI responses without ever being placed on a buyer shortlist. The benchmark distinguishes between these outcomes explicitly. Modeled values assigned to valid top-3 recommendations are not revenue, not pipeline, and not booked sales. They are benchmark estimates of the recommendation opportunity associated with positive shortlist placements, used here to compare relative positioning across the competitive field.

The Citation Layer

AI systems build recommendations from available public evidence. The brands that lead this category in recommendation strength share observable characteristics: clear service descriptions, visible clinical or regulatory credentials, strong review signals, and structured pricing information that is easy to retrieve and compare.

The public evidence layer for at-home STD testing appears to include official brand websites, editorial review articles, health-focused comparison pages, consumer review platforms, directories, and general health publications. Brands with stronger search-visible content across these source types may have an advantage in AI retrievability. The benchmark cannot prove direct causation between any individual source and an AI recommendation, but the source pattern may indicate which brands have built a more complete and consistent public evidence layer.

Nurx benefits from a combination of clinical-telehealth authority and direct-to-consumer positioning that AI systems can retrieve and compare across multiple source types. Its strong recommendation conversion relative to its mention rate suggests that the sources available about Nurx are structured in ways that support positive shortlist placement. Everlywell's high visibility but lower recommendation conversion suggests that AI systems recognize the brand strongly but may lack sufficient structured comparison evidence to rank it consistently across all platforms and prompt clusters.

The gap between raw visibility and recommendation is partly a function of citation architecture. Brands that appear in ranked comparison lists, clinical summaries, transparent pricing pages, and authoritative editorial content give AI systems more material to synthesize into a recommendation. Brands that appear primarily in general mentions or unfocused editorial coverage may be named without being chosen.

Traditional search visibility and backlink strength are part of the public evidence layer and may support AI retrievability, but they do not directly cause AI recommendation outcomes. Search-visible pages create a stronger source footprint and give AI systems more material to synthesize. That relationship is supporting evidence for source strategy, not proof of AI influence.

What Brands Need to Fix

Weak valid recommendation coverage. Brands such as Everlywell and myLAB Box show significant gaps between mention presence and recommendation conversion. The opportunity is not to generate more raw mentions but to convert existing visibility into ranked recommendation positions through stronger entity signals and structured evidence.

Low top-three and rank-one presence. Even brands that receive recommendations often appear at lower average ranks. myLAB Box averages 2.59. LetsGetChecked averages 2.08. Moving up in average recommended rank requires stronger, more consistent evidence across the source types AI systems appear to draw from.

Poor prompt-cluster coverage. Some brands perform well in one cluster but poorly in others. LetsGetChecked is strongest in pricing prompts but weaker in discovery prompts. A brand that covers only one buyer stage is vulnerable to competitor displacement at every other stage of the discovery process.

Neutral or cautionary framing. STDcheck.com and QuestDirect appear in AI responses but with minimal positive framing. Improving framing quality requires stronger third-party validation, clearer service authority signals, and more structured editorial coverage that positions the brand favorably rather than neutrally.

Thin or inconsistent source footprint. Brands with limited search-visible content, weak backlink-supported evidence, or inconsistent entity information across directories and review platforms may struggle to provide AI systems with the structured evidence needed for ranked recommendations. Entity consistency across name, address, service descriptions, and category signals matters.

Underdeveloped pricing and comparison content. The pricing cluster carries the highest commercial intent in this dataset. Brands that do not surface clear, structured pricing information are at a systematic disadvantage in decision-stage prompts, which are the moments when buyers are closest to a purchase decision.

Limited third-party validation and review coverage. In a trust-sensitive health category, third-party endorsements, clinical comparisons, and verified review content appear to support recommendation confidence. Brands without this layer may be named but not advanced.

How CiteWorks Studio Helps

1. Map AI recommendation visibility. Track prompts, platforms, company presence, valid recommendations, top-three and rank-one performance, framing, and citation sources across the at-home STD testing category and adjacent health testing verticals.
2. Identify the sources shaping AI answers. Find the editorial, review, forum, directory, owned, and search-visible sources that influence brand framing and recommendation positioning at each buyer stage.
3. Build the citation architecture plan. Strengthen the public evidence layer so AI systems have more accurate, consistent, and persuasive source material to synthesize when responding to high-intent health testing prompts.

Commercial Takeaway

The at-home STD testing market is experiencing shortlist compression. AI platforms are concentrating recommendations around a small set of brands, and that concentration is likely to intensify as citation patterns solidify and AI systems build reinforcing retrieval histories. Brands that are not in the top recommendation tier face a structural disadvantage in AI-led discovery that compounds over time.

Competitor displacement is already visible in the data. Nurx and Everlywell together capture 20% of the total modeled monthly opportunity, while the remaining eight brands share the rest unevenly. LetsGetChecked and myLAB Box hold middle positions but face pressure from above and erosion from below. The brands at the bottom of the table, including Priority STD Testing and Health Testing Centers, are functionally absent from AI recommendations at the prompt clusters measured. For those brands, AI-led discovery is currently delivering no recommendation-stage value.

For brands that underperform at any tier, the path forward requires stronger entity architecture, better source visibility across the public evidence layer, and deliberate content strategies that align with how AI systems retrieve and compare information in trust-sensitive health categories. Visibility alone is no longer the measure that matters. The benchmark rewards brands that are not just seen in AI answers but recommended within them.

See How AI Is Recommending Your Brand

The benchmark shows where the category stands today. A brand-specific analysis can show where your company appears in AI-generated responses, where competitors are recommended instead, which prompt clusters carry the most commercial risk, which sources appear to be shaping AI answers, and what needs to change to improve recommendation-stage visibility.

Request an AI Visibility Audit or AI Company Discovery Report to understand your brand's position in AI-generated recommendations for at-home health testing.

Benchmark Source

This analysis is based on the 2026 AI Market Discovery Index for At-Home STD Tests, published by LLM Authority Index. The full benchmark dataset includes 10 prompt clusters, platform-by-platform recovery priorities, citation-source failure maps, and company-specific content recommendations not shown in this public analysis. Read the full benchmark report at the LLM Authority Index.